Literature DB >> 25032264

Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease.

N Ma, X Zhang, F Yu, P Gao, Q Fan, L Liu, D Liu.   

Abstract

Recent studies have associated genetic variation near the interleukin 28B (IL28B/IFN-λ3) gene with natural clearance of the hepatitis C virus (HCV) infection, and a common variant in the DEP domain containing 5 (DEPDC5) locus on chromosome 22 has been shown to affect susceptibility to hepatocellular carcinoma (HCC) in Japanese individuals with chronic HCV infection. This study was conducted to determine whether polymorphisms near or in interferon-lambda (IFN-λs) genes and their receptor genes such as interleukin 28 receptor, alpha (IL28RA) and interleukin 10 receptor, beta (IL10RB) as well as p21-activated kinases 4 (PAK4) and iron/zinc purple acid phosphatase-like protein (PAPL), which are locate upstream of IFN-λs, and lastly the DEPDC5 gene are associated with hepatitis B virus-related liver disease in Han Chinese. The study subjects included 507 normal healthy controls, 350 individuals with natural clearance of HBV and 792 HBV-infected patients. The patients were categorized into 157 inactive carriers (Case I), 216 active carriers (Case II), 111 cirrhotics (Case III) and 308 HCC patients (Case IV) subgroups. Seven single nucleotide polymorphisms (SNPs) were genotyped using the Matrix-assisted Laser Desorption/Ionisation mass spectrometric (MALDI-TOF MS) SNP genotyping assay. Rs423058 upstream of PAPL, rs2834167 in IL10RB and rs1012068 in DEPDC5 were associated with chronic HBV status, HBV natural clearance and the presence of HCC (P = 0.0004–0.024), respectively. PAPL, IL10RB and DEPDC5 polymorphisms have an impact on progression of HBV-related liver disease. However, IFN-λs genes as a tool to differentiate between different clinical courses of HBV infection were not useful in the Han Chinese population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25032264     DOI: 10.1111/jvh.12235

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  Identification of DEP domain-containing proteins by a machine learning method and experimental analysis of their expression in human HCC tissues.

Authors:  Zhijun Liao; Xinrui Wang; Yeting Zeng; Quan Zou
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

2.  Role of GSPT1 and GSPT2 polymorphisms in different outcomes upon Hepatitis B virus infection and prognosis to lamivudine therapy.

Authors:  Wenxuan Liu; Ning Ma; Xia Gao; Wencong Liu; Jinhai Jia; Longmei Tang; Man Li; Lei Yang; Tao Li; Lina Yan; Xiaolin Zhang; Fengxue Yu
Journal:  Biosci Rep       Date:  2019-03-28       Impact factor: 3.840

Review 3.  Host Genetic Determinants of Hepatitis B Virus Infection.

Authors:  Zhenhua Zhang; Changtai Wang; Zhongping Liu; Guizhou Zou; Jun Li; Mengji Lu
Journal:  Front Genet       Date:  2019-08-13       Impact factor: 4.599

4.  The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis.

Authors:  Shaoyou Qin; Jiangbin Wang; Changyu Zhou; Yan Xu; Yonggui Zhang; Xu Wang; Song Wang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 5.  Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.

Authors:  Laura A Novotny; John Grayson Evans; Lishan Su; Haitao Guo; Eric G Meissner
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

6.  Immune implication of FAM83D gene in hepatocellular carcinoma.

Authors:  Tao Meng; Zhong Tong; Ming-Ya Yang; Yan Zhang; Yu Liu; Zhen-Zhen Wang; Li-Xin Zhu; Jin Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.